Efficacy of Adjunctive Low-Level Light Therapy to Intense Pulsed Light for Meibomian Gland Dysfunction

Last updated: November 3, 2024
Sponsor: Chulalongkorn University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Dry Eyes

Blepharitis

Eyelid Inflammation

Treatment

Intense pulsed light (IPL)

Low-level light therapy (LLLT)

Clinical Study ID

NCT06468930
0666/66
  • Ages > 18
  • All Genders

Study Summary

The goal of this clinical trial is to compare the effectiveness of adjunctive low-level light therapy (LLLT) to intense pulsed light (IPL) versus intense pulsed light (IPL) alone for the treatment of meibomian gland dysfunction (MGD).

The main question it aims to answer is does the adjunctive of low-level light therapy (LLLT) to intense pulsed light (IPL) provide more beneficial treatment effects than intense pulsed light (IPL) alone in treating meibomian gland dysfunction (MGD) patients?

Participants will be randomized into 2 groups: adjunctive low-level light therapy (LLLT) to intense pulsed light (IPL) group (ALLLT +IPL) and IPL alone group.

Eligibility Criteria

Inclusion

Inclusion criteria:

  • MGD severity level 2 and above according to the international workshop on MGD

  • Fitzpatrick skin type of 1-4 according to sun sensitivity characteristics andappearance of the skin color

Exclusion

Exclusion Criteria:

  • History of previous ocular trauma or surgery within the past six months

  • Contact lens-wearing patients

  • Patients with skin-pigmented lesions in the treatment area

  • Pregnancy or breastfeeding patients

  • Patients with any uncontrolled ocular or systemic diseases

Study Design

Total Participants: 58
Treatment Group(s): 2
Primary Treatment: Intense pulsed light (IPL)
Phase:
Study Start date:
October 02, 2024
Estimated Completion Date:
May 31, 2025

Study Description

In both the IPL group and the ALLLT+IPL group, the doctor will administer IPL therapy to each participant and apply the Light Modulation® special facial mask to their faces. The assistant nurse will activate the light power, ensuring that the doctor remains blind to treatment allocation. Participants in both groups will receive a conventional treatment for MGD including warm compression and lid hygiene. Moreover, all participants will be advised to use preservative-free artificial tears 4 times daily throughout the study.

Connect with a study center

  • King Chulalongkorn memorial hospital

    Bangkok, 10330
    Thailand

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.